...
机译:Saroglitazar镁的临床前评价,一种用于治疗血脂血症和代谢障碍的双PPAR-α/γ激动剂
Cadila Healthcare Ltd Dept Drug Metab &
Pharmacokinet Zydus Res Ctr Ahmadabad Gujarat India;
Cadila Healthcare Ltd Dept Drug Metab &
Pharmacokinet Zydus Res Ctr Ahmadabad Gujarat India;
Cadila Healthcare Ltd Dept Drug Metab &
Pharmacokinet Zydus Res Ctr Ahmadabad Gujarat India;
Cadila Healthcare Ltd Dept Drug Metab &
Pharmacokinet Zydus Res Ctr Ahmadabad Gujarat India;
Cadila Healthcare Ltd Dept Drug Metab &
Pharmacokinet Zydus Res Ctr Ahmadabad Gujarat India;
Cadila Healthcare Ltd Dept Drug Metab &
Pharmacokinet Zydus Res Ctr Ahmadabad Gujarat India;
Cadila Healthcare Ltd Dept Drug Metab &
Pharmacokinet Zydus Res Ctr Ahmadabad Gujarat India;
Cadila Healthcare Ltd Dept Med Chem Zydus Res Ctr Ahmadabad Gujarat India;
Cadila Healthcare Ltd Dept Pharmacol &
Toxicol Zydus Res Ctr Ahmadabad Gujarat India;
Cadila Healthcare Ltd Dept Drug Metab &
Pharmacokinet Zydus Res Ctr Ahmadabad Gujarat India;
Cadila Healthcare Ltd Dept Drug Metab &
Pharmacokinet Zydus Res Ctr Ahmadabad Gujarat India;
ADME; bioavailability; diabetic dyslipidemia; hepatocyte; metabolism; permeability; pharmacokinetics;
机译:Saroglitazar镁的临床前评价,一种用于治疗血脂血症和代谢障碍的双PPAR-α/γ激动剂
机译:基于结构的对接与分子动力学研究:过氧化物组织增殖物激活的受体 - 用于治疗代谢障碍的α/γ双激动剂
机译:基于结构的对接与分子动力学研究:过氧化物组织增殖物激活的受体 - 用于治疗代谢障碍的α/γ双激动剂
机译:伽马刀治疗代谢评估的自动方法
机译:GABA(B)激动剂治疗可卡因成瘾的神经生物学和临床前评价。
机译:新型双重过氧化物酶体增殖物激活受体激动剂Saroglitazar治疗糖尿病性血脂异常和非酒精性脂肪肝:现实世界证据的综合分析
机译:新的双过氧化物体增殖剂激活受体激动剂-Saroglitazar在糖尿病血脂血症和非酒精性脂肪肝病:对现实世界的综合分析